Skip to main content

Saving Seniors Money on Prescriptions Act (H.R. 950)

Referred to Committee
Introduced 2/4/2025•119th Congress•House

Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2/4/2025 • House

Summary

Saving Seniors Money on Prescriptions Act

This bill establishes reporting requirements for pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage, particularly relating to the prices of prescription drugs.

Specifically, PBMs must (1) disclose certain information underlying cost performance measurements (e.g., exclusions and terms), and (2) report to prescription drug plan (PDP) sponsors (and to the Centers for Medicare & Medicaid Services upon request) an itemized list of prescription drugs that were dispensed during the previous year and related data about costs, claims, affiliated pharmacies, and other specified information. PDP sponsors may audit PBMs to ensure compliance with this bill's requirements and must annually certify their compliance; PBMs are responsible for any associated civil penalties for violations.

In addition, the Government Accountability Office must study federal and state reporting requirements for health plans and PBMs with respect to prescription drug price transparency and recommend ways to streamline these requirements.

Introduced in House • 2/4/2025

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Accounting and auditingCongressional oversightContracts and agencyDrug safety, medical device, and laboratory regulationGovernment information and archivesGovernment studies and investigationsHealth care costs and insurancePrescription drugsRetail and wholesale trades

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (3)

Party Breakdown

2
Democrats
1
Republicans
0
Independents

Sponsor

R[
Rep. Landsman, Greg [D-OH-1]

Democrat • OH-1

Sponsored 2/4/2025

Cosponsors (2)

R[
R[
Rep. Suozzi, Thomas R. [D-NY-3]

D-NY-3

Joined 1/20/2026

Bill Journey

Originated in the House

Introduced

February 4, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House2/4/2025

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors2

Sources and method

· Record updated Feb 5, 2026
  • Congress.govLibrary of Congress
    Status, actions, sponsors, cosponsors, committees and text
    Record updated Feb 5, 2026 · Loaded Nov 2, 2026, 2:40 AM ET
  • CRS bill summaryCongressional Research Service, via Congress.gov
    Official summary
    Summary of the “Introduced in House” version, Feb 4, 2025 · Loaded Nov 2, 2026, 2:40 AM ET
  • USAspending.govU.S. Department of the Treasury
    Related Federal Spending section
  • FEC filingsFederal Election Commission
    Funding & Lobbying section
  • Lobbying disclosures (LDA)Secretary of the Senate and Clerk of the House
    Funding & Lobbying section

All sources: Public domain (17 U.S.C. § 105) · Method: Data sources → · Campaign finance →

AI-written text on this page is labeled where it appears. It is written from the sources above and is not a source itself. How we analyze data →

Dates shown where the source reports one. “Loaded” is when CIV.IQ last fetched the record.